12th Drug Information Association (DIA) Middle East Regulatory Conference (MERC)
In-Person Event
Nov 21 - 22, 2017
Kuwait City, Al-Asima, KW
OVERVIEW
12th Drug Information Association (DIA) Middle East Regulatory Conference (MERC) is organized by Drug Information Association Europe, Middle East and Africa (DIA EMEA) and would be held during Nov 21 - 22, 2017 at Millennium Hotel and Convention Centre Kuwait, Kuwait City, Al-Asima, Kuwait.
The target audience for this medical event for key stakeholders active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.
The 12th DIA Middle East Regulatory Conference (MERC), in partnership with the Middle East Regulatory Network (MERN), is built on the premise that collaboration leads to higher impact innovation. This conference, growing in scale every year, brings together health authorities from across the region and Europe. Speakers will discuss country-level progress and challenges, as well as opportunities for increased regional collaboration.
Learning objectives are :
• Updates from authorities in operating in the region
• Facilitated regulatory pathways
• Life cycle management
• Safety Labelling updates
• Pharmacovigilance in the Middle East
Top 3 Reasons to Attend:
• Collaborate with Health Authorities – Don’t miss this chance to get behind-the-scenes exposure to the future of health policy in the region
• Connect with 300 participants, representing 27 countries from health authorities and pharmaceutical industry, throughout the Middle East and Europe
• Establish leading strategies and processes for getting breakthrough medicines to patients faster
Key Topics:
• Good Regulatory Practice
• Expedited Pathways
• Life Cycle Management
• Pharmacovigilance
• Barcoding and Serialisation
• Innovation
Additional details will be posted as soon as they are available.
The target audience for this medical event for key stakeholders active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.
The 12th DIA Middle East Regulatory Conference (MERC), in partnership with the Middle East Regulatory Network (MERN), is built on the premise that collaboration leads to higher impact innovation. This conference, growing in scale every year, brings together health authorities from across the region and Europe. Speakers will discuss country-level progress and challenges, as well as opportunities for increased regional collaboration.
Learning objectives are :
• Updates from authorities in operating in the region
• Facilitated regulatory pathways
• Life cycle management
• Safety Labelling updates
• Pharmacovigilance in the Middle East
Top 3 Reasons to Attend:
• Collaborate with Health Authorities – Don’t miss this chance to get behind-the-scenes exposure to the future of health policy in the region
• Connect with 300 participants, representing 27 countries from health authorities and pharmaceutical industry, throughout the Middle East and Europe
• Establish leading strategies and processes for getting breakthrough medicines to patients faster
Key Topics:
• Good Regulatory Practice
• Expedited Pathways
• Life Cycle Management
• Pharmacovigilance
• Barcoding and Serialisation
• Innovation
Additional details will be posted as soon as they are available.
KEY DATES
21 Nov, 2017
Event Start Date
22 Nov, 2017
Event End Date
SPECIALITIES
Healthcare ManagementSUGGESTED HOTELS
CONFERENCE VENUE
Millennium Hotel and Convention Centre KuwaitRELATED CONFERENCES & LIVE WEBINARS
Quick Links